Overview
A Study of MK0594 in Patients With Alcohol Dependence (0594-020)
Status:
Terminated
Terminated
Trial end date:
2010-03-11
2010-03-11
Target enrollment:
0
0
Participant gender:
All
All
Summary
A study in patients with alcohol dependence to see if MK0594 is safe and effective in maintaining absence of heavy drinking over a 12-week treatment period.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.
Vyne Therapeutics Inc.
Criteria
Inclusion Criteria:- Patient has Diagnostic and Statistical Manual of Mental Disorders, fourth edition,
text revision diagnosis of alcohol dependence and alcohol addiction
- Patient has two heavy drinking days in the last 30 days
- Patient has 3 days of abstinence from alcohol right before taking study medication
- Patient has lived in the same residence for the last 2 months
Exclusion Criteria:
- If female, patient is pregnant or breastfeeding
- Patient anticipated inpatient alcohol treatment
- Patient has a history of suicide attempt in the last year
- Patient has schizophrenia or bipolar disorder
- Patient has a history of multiple or serious allergies
- Patient has participated in a clinical trial in the last 30 days